Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 26Pancreatic Neoplasms 11Stomach Neoplasms 10Rectal Neoplasms 10Colonic Neoplasms 10Esophageal Neoplasms 8Adenocarcinoma Of Esophagus 8Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Neoplasms 5Cholangiocarcinoma 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Squamous Cell Carcinoma of Head and Neck 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Ovarian Neoplasms 2Melanoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urogenital Neoplasms 1

Interventions

Specimen Handling 3Magnetic Resonance Spectroscopy 2pembrolizumab 1dehydroftorafur 1atezolizumab 1Oxaliplatin 1Naproxen 1Leucovorin 1Fluorouracil 1Diffusion Tensor Imaging 1Colonoscopy 1Biopsy 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colorectal Neoplasms, Hereditary Nonpolyposis × Fluorouracil × 30 days × Clear all
NCT02912559 2026-06-01

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

National Cancer Institute (NCI)

Phase 3 Active not recruiting
712 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡